Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company based in Rockville, Maryland, specializing in pioneering cancer therapies that harness the body's immune system. The company's robust pipeline features innovative treatments designed to effectively stimulate immune responses to target and eliminate tumors. With a strategic commitment to advancing biotechnology and improving patient outcomes, Sensei is well-equipped to play a significant role in the evolving oncology landscape, addressing the growing need for efficacious and targeted cancer treatments. Show more
Location: 1405 RESEARCH BOULEVARD, ROCKVILLE, MD, UNITED STATES, 20850, Rockville, MD, 20850, USA | Website: https://www.senseibio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
11.98M
52 Wk Range
$5.00 - $18.35
Previous Close
$9.50
Open
$9.38
Volume
147,970
Day Range
$8.90 - $9.76
Enterprise Value
-11.04M
Cash
10.56M
Avg Qtr Burn
-3.586M
Insider Ownership
32.08%
Institutional Own.
3.98%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
SNS-401-NG Details Cancer, Carcinoma | Failed Discontinued | |
SNS-301 Details Head and neck cancer, Cancer, Head and neck squamous cell carcinoma | Failed Discontinued | |
Solnerstotug (formerly SNS-101) Details Cancer, Solid tumor/s | Failed Discontinued |
